MicroTech Medical Hangzhou Co Ltd
HKEX:2235
MicroTech Medical Hangzhou Co Ltd
HKEX:2235
Price:
6.3
HKD
5.7%
Market Closed
Market Cap:
2.6B
HKD
Balance Sheet
Balance Sheet Decomposition
MicroTech Medical Hangzhou Co Ltd
MicroTech Medical Hangzhou Co Ltd
| Current Assets | 2B |
| Cash & Short-Term Investments | 1.8B |
| Receivables | 88.4m |
| Other Current Assets | 84.8m |
| Non-Current Assets | 186.6m |
| PP&E | 151.3m |
| Intangibles | 32.7m |
| Other Non-Current Assets | 2.5m |
Balance Sheet
MicroTech Medical Hangzhou Co Ltd
MicroTech Medical Hangzhou Co Ltd
Currency: CNY
Millions
Annual
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
22
|
118
|
2 151
|
2 047
|
1 886
|
|
| Cash |
22
|
118
|
1 586
|
1 084
|
1 886
|
|
| Cash Equivalents |
0
|
0
|
565
|
962
|
0
|
|
| Short-Term Investments |
142
|
537
|
0
|
0
|
6
|
|
| Total Receivables |
19
|
12
|
32
|
54
|
79
|
|
| Accounts Receivables |
7
|
10
|
28
|
49
|
73
|
|
| Other Receivables |
12
|
1
|
5
|
4
|
6
|
|
| Inventory |
9
|
18
|
34
|
67
|
42
|
|
| Other Current Assets |
3
|
3
|
16
|
12
|
14
|
|
| Total Current Assets |
196
|
688
|
2 233
|
2 177
|
2 023
|
|
| PP&E Net |
53
|
75
|
82
|
98
|
102
|
|
| PP&E Gross |
53
|
75
|
82
|
98
|
102
|
|
| Accumulated Depreciation |
5
|
7
|
13
|
21
|
30
|
|
| Intangible Assets |
16
|
14
|
14
|
19
|
34
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
265
N/A
|
777
+194%
|
2 329
+200%
|
2 294
-2%
|
2 159
-6%
|
|
| Liabilities | ||||||
| Accounts Payable |
5
|
8
|
14
|
23
|
34
|
|
| Accrued Liabilities |
8
|
12
|
21
|
40
|
35
|
|
| Short-Term Debt |
10
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
24
|
29
|
47
|
16
|
24
|
|
| Total Current Liabilities |
48
|
49
|
82
|
79
|
93
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
3
|
4
|
|
| Total Liabilities |
48
N/A
|
49
+2%
|
82
+69%
|
82
-1%
|
98
+19%
|
|
| Equity | ||||||
| Common Stock |
74
|
360
|
426
|
426
|
426
|
|
| Retained Earnings |
142
|
132
|
97
|
1 786
|
1 661
|
|
| Additional Paid In Capital |
0
|
236
|
1 724
|
1 724
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
26
|
|
| Total Equity |
217
N/A
|
729
+236%
|
2 247
+208%
|
2 212
-2%
|
2 061
-7%
|
|
| Total Liabilities & Equity |
265
N/A
|
777
+194%
|
2 329
+200%
|
2 294
-2%
|
2 159
-6%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
424
|
424
|
426
|
426
|
426
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
